A synthetic mechano growth factor E peptide enhances myogenic precursor cell transplantation success

American Journal of Transplantation

Volumn 7, Issue 10, 2007, Pages 2247-2259

  Mills, P ^a   Dominique, J C ^a   Lafreniere J F ^a   Bouchentouf, M ^a   Tremblay, J P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Differentiation; MGF; Muscle hypertrophy; Muscular dystrophy; Myoblasts; Proliferation; Transplantation

Indexed keywords

GROWTH FACTOR; MECHANO GROWTH FACTOR CT24E; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DUCHENNE MUSCULAR DYSTROPHY; ENGRAFTMENT; HUMAN; HUMAN CELL; MALE; MOUSE; MYOGENIC PRECURSOR CELL; MYOGENIC PRECURSOR CELL TRANSPLANTATION; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR BINDING; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; CHILD; DYSTROPHIN; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, SCID; MUSCLE, SKELETAL; RNA, MESSENGER; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 34548348920     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01927.x     Document Type: Article

References (76)

1. Skuk D, Goulet M, Roy B et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006 65 : 371 386.
2. Skuk D, Roy B, Goulet M et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenics cells. Mol Ther 2004 9 : 475 482.
3. Skuk D, Goulet M, Roy B et al. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 2006.
4. Skuk D, Caron N, Goulet M, Roy B, Espinosa F, Tremblay JP. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant 2002 11 : 671 681.
5. El Fahime E, Bouchentouf M, Benabdallah BF et al. Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem Cell Biol 2003 81 : 81 90.
6. Skuk D. Myoblast transplantation for inherited myopathies: A clinical approach. Expert Opin Biol Ther 2004 4 : 1871 1885.
7. Kinoshita I, Vilquin JT, Tremblay JP. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 1995 18 : 834 841.
8. White JD, Bower JJ, Kurek JB, Austin L. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation. Muscle Nerve 2001 24 : 695 697.
9. Bower JJ, White JD, Kurek JB, Muldoon CM, Austin L. The role of growth factors in myoblast transfer therapy. Basic Appl Myol 1997 7 : 177 186.
10. Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004 77 : 1349 1356.
11. El Fahime E, Mills P, Lafreniere JF, Torrente Y, Tremblay JP. The urokinase plasminogen activator: An interesting way to improve myoblast migration following their transplantation. Exp Cell Res 2002 280 : 169 178.
12. El Fahime E, Torrente Y, Caron NJ, Bresolin MD, Tremblay JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 2000 258 : 279 287.
13. Lafreniere JF, Mills P, Tremblay JP, Fahime EE. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 2004 77 : 1741 1747.
14. Lafreniere JF, Mills P, Bouchentouf M, Tremblay JP. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 2006 312 : 1127 1141.
15. Mills P, Lafreniere JF, Benabdallah BF, El Fahime el M, Tremblay JP. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res 2007 313 : 527 537.
16. Allen RE, Boxhorn LK. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 1989 138 : 311 315.
17. Florini JR. Hormonal control of muscle growth. Muscle Nerve 1987 10 : 577 598.
18. Bodine SC, Stitt TN, Gonzalez M et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001 3 : 1014 1019.
19. Rommel C, Bodine SC, Clarke BA et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001 3 : 1009 1013.
20. Napier JR, Thomas MF, Sharma M, Hodgkinson SC, Bass JJ. Insulin-like growth factor-I protects myoblasts from apoptosis but requires other factors to stimulate proliferation. J Endocrinol 1999 163 : 63 68.
21. Galvin CD, Hardiman O, Nolan CM. IGF-1 receptor mediates differentiation of primary cultures of mouse skeletal myoblasts. Mol Cell Endocrinol 2003 200 : 19 29.
22. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 2001 276 : 39264 39270.
23. McKoy G, Ashley W, Mander J et al. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 1999 516 (Pt 2 583 592.
24. Vandenburgh H, Chromiak J, Shansky J, Del Tatto M, Lemaire J. Space travel directly induces skeletal muscle atrophy. FASEB J 1999 13 : 1031 1038.
25. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: Relation to age and adiposity. J Clin Invest 1981 67 : 1361 1369.
26. Ravaglia G, Forti P, Maioli F et al. Body composition, sex steroids, IGF-1, and bone mineral status in aging men. J Gerontol A Biol Sci Med Sci 2000 55 : M516 M521.
27. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 1997 138 : 4153 4159.
28. Verhaar HJ, Samson MM, Jansen PA, de Vreede PL, Manten JW, Duursma SA. Muscle strength, functional mobility and vitamin D in older women. Aging (Milano) 2000 12 : 455 460.
29. Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 2003 549 (Pt 2 409 418.
30. Chew SL, Lavender P, Clark AJ, Ross RJ. An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 1995 136 : 1939 1944.
31. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989 10 : 68 91.
32. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999 400 : 581 585.
33. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998 95 : 15603 15607.
34. Yang S, Alnaqeeb M, Simpson H, Goldspink G. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 1996 17 : 487 495.
35. Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003 203 : 89 99.
36. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, Cuttitta F. A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci USA 1992 89 : 8107 8111.
37. Kuo YH, Chen TT. Novel activities of pro-IGF-I E peptides: Regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp Cell Res 2002 280 : 75 89.
38. Kuo YH, Chen TT. Specific cell surface binding sites shared by human Pro-IGF-I Eb-peptides and rainbow trout Pro-IGF-I Ea-4-peptide. Gen Comp Endocrinol 2003 132 : 231 240.
39. Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 2002 522 : 156 160.
40. Allen RE, Rankin LL, Greene EA et al. Desmin is present in proliferating rat muscle satellite cells but not in bovine muscle satellite cells. J Cell Physiol 1991 149 : 525 535.
41. Kaufman SJ, Foster RF. Replicating myoblasts express a muscle-specific phenotype. Proc Natl Acad Sci USA 1988 85 : 9606 9610.
42. Kinoshita I, Vilquin JT, Guerette B, Asselin I, Roy R, Tremblay JP. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994 17 : 1407 1415.
43. Qu-Petersen Z, Deasy B, Jankowski R et al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 2002 157 : 851 864.
44. Camirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant 2004 4 : 1255 1265.
45. Rochat A, Fernandez A, Vandromme M et al. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol Biol Cell 2004 15 : 4544 4555.
46. Florini JR, Ewton DZ. Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. No effects on other actions of IGF-T. J Biol Chem 1990 265 : 13435 13437.
47. Sun XJ, Rothenberg P, Kahn CR et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991 352 : 73 77.
48. Sun XJ, Miralpeix M, Myers MG Jr. et al. Expression and function of IRS-1 in insulin signal transmission. J Biol Chem 1992 267 : 22662 22672.
49. Myers MG, Jr., Sun XJ, Cheatham B et al. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. Endocrinology 1993 132 : 1421 1430.
50. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994 211 : 314 321.
51. Yue Y, Lypowy J, Hedhli N, Abdellatif M. Ras GTPase-activating protein binds to Akt and is required for its activation. J Biol Chem 2004 279 : 12883 12889.
52. Guerette B, Asselin I, Skuk D, Entman M, Tremblay JP. Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant 1997 6 : 101 107.
53. Skuk D, Caron NJ, Goulet M, Roy B, Tremblay JP. Resetting the problem of cell death following muscle-derived cell transplantation: Detection, dynamics and mechanisms. J Neuropathol Exp Neurol 2003 62 : 951 967.
54. Bouchentouf M, Benabdallah BF, Rousseau J, Schwartz LM, Tremblay JP. Induction of Anoikis Following Myoblast Transplantation into SCID Mouse Muscles Requires the Bit1 and FADD Pathways. Am J Transplant 2007 7 : 1491 1505.
55. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994 93 : 586 599.
56. Vilquin JT, Asselin I, Guerette B, Kinoshita I, Roy R, Tremblay JP. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995 59 : 422 426.
57. Brimah K, Ehrhardt J, Mouly V, Butler-Browne GS, Partridge TA, Morgan JE. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum Gene Ther 2004 15 : 1109 1124.
58. Jennische E, Ekberg S, Matejka GL. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am J Physiol 1993 265 (1 Pt 1 C122 C128.
59. Kami K, Senba E. Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle Nerve 1998 21 : 819 822.
60. Lefaucheur JP, Sebille A. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J Neuroimmunol 1995 57 : 85 91.
61. Lefaucheur JP, Sebille A. The cellular events of injured muscle regeneration depend on the nature of the injury. Neuromuscul Disord 1995 5 : 501 509.
62. Pavlath GK, Thaloor D, Rando TA, Cheong M, English AW, Zheng B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev Dyn 1998 212 : 495 508.
63. Conboy IM, Rando TA. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 2002 3 : 397 409.
64. Crown AL, He XL, Holly JM, Lightman SL, Stewart CE. Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol 2000 167 : 403 415.
65. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999 20 : 761 787.
66. Sacco A, Doyonnas R, LaBarge MA, Hammer MM, Kraft P, Blau HM. IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. J Cell Biol 2005 171 : 483 492.
67. Schertzer JD, Lynch GS. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther 2006 13 : 1657 1664.
68. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol 2002 161 : 2263 2272.
69. Gregorevic P, Plant DR, Lynch GS. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve 2004 30 : 295 304.
70. Lavasani M, Lu A, Peng H, Cummins J, Huard J. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle. Hum Gene Ther 2006 17 : 180 192.
71. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002 157 : 137 148.
72. Jacquemin V, Furling D, Bigot A, Butler-Browne GS, Mouly V. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp Cell Res 2004 299 : 148 158.
73. Jacquemin V, Butler-Browne GS, Furling D, Mouly V. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes. J Cell Sci 2007 120 (Pt 4 670 681.
74. Goldspink G. Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol 2006 38 : 481 489.
75. Barton ER. Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J Appl Physiol 2006 100 : 1778 1784.
76. Cortes E, te Fong LF, Hameed M et al. Insulin-like growth factor-1 gene splice variants as markers of muscle damage in levator ani muscle after the first vaginal delivery. Am J Obstet Gynecol 2005 193 : 64 70.